Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Development of the Lymphatic System01:15

Development of the Lymphatic System

2.8K
The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
2.8K
Lymphatic Vessels and Lymph Transport01:16

Lymphatic Vessels and Lymph Transport

13.6K
Lymphatic vessels, known as lymphatics, are crucial in transporting lymph from peripheral tissues to our venous system. This process begins with lymph entering through tiny capillaries that branch through tissues. These capillaries have unique features such as larger diameters, thinner walls, and a distinctive one-way valve system formed by overlapping endothelial cells.
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular...
13.6K
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

20
Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous...
20
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

469
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
469
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

28
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
28

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness.

Epilepsia·2026
Same author

Real-world outcomes of responsive neurostimulation in patients with Lennox-Gastaut syndrome: A multicenter retrospective study.

Epilepsia open·2026
Same author

Expanding the scope of pediatric epilepsy surgery: Access, indications, and outcomes in a modern cohort.

Epilepsia open·2026
Same author

Diagnostic yield of chromosomal microarray and virtual targeted gene panel analysis in adults with focal epilepsy: implications for sequential genetic testing strategy.

Seizure·2026
Same author

Characterizing early behavioral and social-emotional problems in young children with SCN1A+ Dravet syndrome: Findings from the ENVISION prospective natural history study.

Epilepsia·2026
Same author

Efficacy and tolerability of blue-tinted contact lenses in the treatment of Sunflower syndrome: A questionnaire-based study.

Epilepsy & behavior : E&B·2026

Related Experiment Video

Updated: May 1, 2026

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
07:36

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

13.8K

Lymphedema in tuberous sclerosis complex.

Alexandra L Geffrey1, Julianna E Shinnick, Brigid A Staley

  • 1Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts.

American Journal of Medical Genetics. Part A
|March 27, 2014
PubMed
Summary
This summary is machine-generated.

Tuberous Sclerosis Complex (TSC) is linked to lymphedema, a condition affecting fluid buildup. This study found a higher frequency of lymphedema in TSC patients, particularly females, suggesting a gender-specific manifestation.

Keywords:
edemalymphatic abnormalitieslymphedematuberous sclerosis complex

More Related Videos

A Murine Tail Lymphedema Model
04:38

A Murine Tail Lymphedema Model

Published on: February 10, 2021

5.9K
A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice
09:50

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice

Published on: November 2, 2019

7.6K

Related Experiment Videos

Last Updated: May 1, 2026

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
07:36

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

13.8K
A Murine Tail Lymphedema Model
04:38

A Murine Tail Lymphedema Model

Published on: February 10, 2021

5.9K
A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice
09:50

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice

Published on: November 2, 2019

7.6K

Area of Science:

  • Genetics and rare diseases
  • Vascular disorders
  • Oncology

Background:

  • Tuberous Sclerosis Complex (TSC) is a genetic disorder affecting multiple organs.
  • Congenital lymphedema is a rare but reported association with TSC.
  • The mammalian target of rapamycin (mTOR) pathway is implicated in TSC pathogenesis.

Purpose of the Study:

  • To investigate the frequency and characteristics of lymphedema in a large cohort of Tuberous Sclerosis Complex patients.
  • To determine if lymphedema is more prevalent in TSC than in the general population.
  • To explore potential gender-specific patterns of lymphedema in TSC.

Main Methods:

  • Retrospective review of medical records for 268 Tuberous Sclerosis Complex patients.
  • Identification of cases with lymphedema or edema of unknown etiology.
  • Collection of genotypic and phenotypic data.

Main Results:

  • Ten new cases of lymphedema in TSC patients were identified (4% prevalence).
  • Two new cases of congenital lymphedema were reported, both in females.
  • Eight cases of acquired lymphedema were also found.
  • Patients with TSC and lymphedema were more likely to be female with renal angiomyolipomas (AMLs).

Conclusions:

  • Lymphedema occurs more frequently in Tuberous Sclerosis Complex patients than in the general population.
  • Congenital lymphedema in TSC appears to be a gender-specific (female) manifestation.
  • Further research into mTOR antagonists may be beneficial for treating lymphedema in TSC.